Which strategies help prevent hypothermia and shivering in the perioperative period?

Which strategies help prevent hypothermia and shivering in the perioperative period?

• A. Pre-warm the patient
• B. Use warming blankets and fluid warmers
• C. Pharmacologic measures such as meperidine or dexmedetomidine
• D. All of the above

Answer: (D)

Preventing perioperative hypothermia and shivering requires a multimodal approach that keeps the patient warm from the start and through emergence, while also addressing shivering if it occurs. Starting with pre-warming fills the peripheral tissues with heat before anesthesia lowers the big drop in core temperature that often happens after induction. This reduces both the likelihood of hypothermia and the need for shivering afterward. Using warming blankets and warming intravenous fluids helps maintain body temperature by minimizing heat loss and supplying heat directly to the patient. These simple, practical measures are effective in keeping core temperature stable when the patient is exposed to cold operating-room conditions and chilly IV fluids. Pharmacologic measures add an anti-shivering effect when needed. Meperidine has a well-known anti-shivering action through its specific receptor effects, and dexmedetomidine, an alpha-2 agonist, also reduces the shivering threshold while providing sedation and analgesia. Together with physical warming strategies, these drugs help prevent or attenuate shivering without relying on higher anesthesia doses. Because each approach targets a different aspect of thermoregulation and shivering, combining them provides the most reliable protection. Hence, using pre-warming, active warming devices, and pharmacologic anti-shivering measures together is the best strategy to prevent both hypothermia and shivering.

Preventing perioperative hypothermia and shivering requires a multimodal approach that keeps the patient warm from the start and through emergence, while also addressing shivering if it occurs. Starting with pre-warming fills the peripheral tissues with heat before anesthesia lowers the big drop in core temperature that often happens after induction. This reduces both the likelihood of hypothermia and the need for shivering afterward.

Using warming blankets and warming intravenous fluids helps maintain body temperature by minimizing heat loss and supplying heat directly to the patient. These simple, practical measures are effective in keeping core temperature stable when the patient is exposed to cold operating-room conditions and chilly IV fluids.

Pharmacologic measures add an anti-shivering effect when needed. Meperidine has a well-known anti-shivering action through its specific receptor effects, and dexmedetomidine, an alpha-2 agonist, also reduces the shivering threshold while providing sedation and analgesia. Together with physical warming strategies, these drugs help prevent or attenuate shivering without relying on higher anesthesia doses.

Because each approach targets a different aspect of thermoregulation and shivering, combining them provides the most reliable protection. Hence, using pre-warming, active warming devices, and pharmacologic anti-shivering measures together is the best strategy to prevent both hypothermia and shivering.